Isolation and characterization of a novel choline degrading Citrobacter amalonaticus strain from the human gut

Gut microbiota metabolism can have profound effects on human health. Choline, a quaternary amine (QA) highly abundant in our diet, is canonically cleaved by a glycyl radical enzyme, choline trimethylamine lyase (CutC), and its SAM-dependent radical activator, CutD. CutC cleaves choline to form trime...

Full description

Bibliographic Details
Main Authors: Jyoti Kashyap, Jeffery R. Ringiesn, Nathan Schwab, Donald J. Ferguson, Jr.
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Current Research in Microbial Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666517422000542
_version_ 1811178528550420480
author Jyoti Kashyap
Jeffery R. Ringiesn
Nathan Schwab
Donald J. Ferguson, Jr.
author_facet Jyoti Kashyap
Jeffery R. Ringiesn
Nathan Schwab
Donald J. Ferguson, Jr.
author_sort Jyoti Kashyap
collection DOAJ
description Gut microbiota metabolism can have profound effects on human health. Choline, a quaternary amine (QA) highly abundant in our diet, is canonically cleaved by a glycyl radical enzyme, choline trimethylamine lyase (CutC), and its SAM-dependent radical activator, CutD. CutC cleaves choline to form trimethylamine (TMA) and acetaldehyde. TMA is oxidized to TMAO by FMO3 in the liver, which plays a role in causing atherosclerosis. We hypothesized that alternative pathways for choline degradation occur within gut microbes and that certain gut microbiota can anaerobically respire or ferment QAs, such as choline. Based on this prediction we established QA-supplemented enrichment cultures using fecal material from healthy volunteers as the inocula. We have isolated, from a choline-supplemented enrichment of a human fecal sample, a strain of Citrobacter amalonaticus, that we have designated CJ25. This strain is capable of anaerobically utilizing choline as its sole carbon and energy source. Its genome does not contain the cutCD genes or genes encoding any COG5598 methyltransferases. We have confirmed the degradation of choline and production of acetate by the organism during growth of the strain. However, we used multiple analytical methods to confirm that no TMA accumulated in the medium during growth. Hence, strain CJ25 is a unique bacterium that degrades choline without the production of the proatherogenic metabolite TMA.
first_indexed 2024-04-11T06:20:57Z
format Article
id doaj.art-a70b5053cb2742eb8698ec0b8701af01
institution Directory Open Access Journal
issn 2666-5174
language English
last_indexed 2024-04-11T06:20:57Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Current Research in Microbial Sciences
spelling doaj.art-a70b5053cb2742eb8698ec0b8701af012022-12-22T04:40:36ZengElsevierCurrent Research in Microbial Sciences2666-51742022-01-013100157Isolation and characterization of a novel choline degrading Citrobacter amalonaticus strain from the human gutJyoti Kashyap0Jeffery R. Ringiesn1Nathan Schwab2Donald J. Ferguson, Jr.3Miami University, Oxford, OH 45056, United StatesMiami University, Oxford, OH 45056, United StatesMiami University, Oxford, OH 45056, United StatesMiami University, Oxford, OH 45056, United States; Miami University, Hamilton, OH, United States; Corresponding author.Gut microbiota metabolism can have profound effects on human health. Choline, a quaternary amine (QA) highly abundant in our diet, is canonically cleaved by a glycyl radical enzyme, choline trimethylamine lyase (CutC), and its SAM-dependent radical activator, CutD. CutC cleaves choline to form trimethylamine (TMA) and acetaldehyde. TMA is oxidized to TMAO by FMO3 in the liver, which plays a role in causing atherosclerosis. We hypothesized that alternative pathways for choline degradation occur within gut microbes and that certain gut microbiota can anaerobically respire or ferment QAs, such as choline. Based on this prediction we established QA-supplemented enrichment cultures using fecal material from healthy volunteers as the inocula. We have isolated, from a choline-supplemented enrichment of a human fecal sample, a strain of Citrobacter amalonaticus, that we have designated CJ25. This strain is capable of anaerobically utilizing choline as its sole carbon and energy source. Its genome does not contain the cutCD genes or genes encoding any COG5598 methyltransferases. We have confirmed the degradation of choline and production of acetate by the organism during growth of the strain. However, we used multiple analytical methods to confirm that no TMA accumulated in the medium during growth. Hence, strain CJ25 is a unique bacterium that degrades choline without the production of the proatherogenic metabolite TMA.http://www.sciencedirect.com/science/article/pii/S2666517422000542CholineQuaternary amineAnaerobic culturingTrimethylamineGut microbiomePyruvate-formate lyase
spellingShingle Jyoti Kashyap
Jeffery R. Ringiesn
Nathan Schwab
Donald J. Ferguson, Jr.
Isolation and characterization of a novel choline degrading Citrobacter amalonaticus strain from the human gut
Current Research in Microbial Sciences
Choline
Quaternary amine
Anaerobic culturing
Trimethylamine
Gut microbiome
Pyruvate-formate lyase
title Isolation and characterization of a novel choline degrading Citrobacter amalonaticus strain from the human gut
title_full Isolation and characterization of a novel choline degrading Citrobacter amalonaticus strain from the human gut
title_fullStr Isolation and characterization of a novel choline degrading Citrobacter amalonaticus strain from the human gut
title_full_unstemmed Isolation and characterization of a novel choline degrading Citrobacter amalonaticus strain from the human gut
title_short Isolation and characterization of a novel choline degrading Citrobacter amalonaticus strain from the human gut
title_sort isolation and characterization of a novel choline degrading citrobacter amalonaticus strain from the human gut
topic Choline
Quaternary amine
Anaerobic culturing
Trimethylamine
Gut microbiome
Pyruvate-formate lyase
url http://www.sciencedirect.com/science/article/pii/S2666517422000542
work_keys_str_mv AT jyotikashyap isolationandcharacterizationofanovelcholinedegradingcitrobacteramalonaticusstrainfromthehumangut
AT jefferyrringiesn isolationandcharacterizationofanovelcholinedegradingcitrobacteramalonaticusstrainfromthehumangut
AT nathanschwab isolationandcharacterizationofanovelcholinedegradingcitrobacteramalonaticusstrainfromthehumangut
AT donaldjfergusonjr isolationandcharacterizationofanovelcholinedegradingcitrobacteramalonaticusstrainfromthehumangut